Stock Events

Protagenic Therapeutics 

$0.71
9
-$0.01-1.39% Today

Statistics

Day High
-
Day Low
-
52W High
2.22
52W Low
0.68
Volume
0
Avg. Volume
12,629
Mkt Cap
3.21M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

15MayExpected
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q3 2023
Q1 2024
-0.38
-0.26
-0.13
0
Expected EPS
N/A
Actual EPS
-0.3829

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PTIX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Internet Software/Services
Technology Services
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.
Show more...
CEO
Employees
1
Country
US
ISIN
US74365N1037
WKN
000A2AP0W

Listings